OSU pathology home page

Preeti Pancholi, PhD, D(ABMM)

Professor-Clinical

Preeti Pancholi, PhD

Phone:

614-257-3488

E-mail:

Email Dr. Pancholi

Mailing Address:

OSU Hospital East
181 Taylor Ave
Columbus, OH 43203

Biosketch

Preeti Pancholi, PhD is a Professor-Clinical and Director of the Clinical Microbiology Laboratory. She earned her PhD in Microbiology and Immunology at the Post Graduate Institute of Medical Education & Research in Chandigarh, India. She completed a postdoctoral fellowship at Rockefeller University in New York, NY. She then completed a Clinical Microbiology fellowship at the Mayo Clinic in Rochester, MN. Dr. Pancholi was Assistant Professor at the New York Blood Center, NYC. She was Associate Director, Clinical Microbiology and Molecular Diagnostics at Columbia-Presbyterian Medical Center, NYC. Dr. Pancholi is board certified in Clinical and Public Health Microbiology by the American Board of Medical Microbiology and has over 20 years of experience in clinical microbiology. Dr. Pancholi’s primary research interests are the use of molecular and other rapid technologies to improve clinical infectious disease diagnostics and, further, to evaluate the impact of these technologies on patient care.

Board Certifications

D(ABMM), American Board of Medical Microbiology

Academic and Medical Appointments

2006-presentDirector, Clinical Microbiology, The Ohio State University College of Medicine, Columbus, OH

2013-presentProfessor, Department of Pathology, The Ohio State University College of Medicine, Columbus, OH

Education and Training

1993-1995 Fellow, Department of Laboratory Medicine Division of Clinical Microbiology, Mayo Clinic, Rochester, MN

1989-1993 Postdoctoral Fellow, Department of Cellular Physiology & Immunology, The Rockefeller University, New York, NY

1984-1988 Ph.D., Microbiology & Immunology, Post‐Graduate Institute of Medical Education & Research, Chandigarh, India

Selected Publications

Search in PubMed

Book Chapters:

  • Graf EH, Pancholi P. Appropriate Use and Future Directions of Molecular Diagnostic Testing. Curr Infect Dis Rep. 2020 Feb 6;22(2):5. doi: 10.1007/s11908-020-0714-5. PMID:32030534
  • Pancholi, P and Martin, S (2015). Cytomegalovirus. Clinical Virology Manual, ASM Press.
  • Marlowe EM, Pancholi P. Molecular microbiology: diagnostic principles and practice. In: Molecular Detection of Group B. streptococcus. Persing DH, Tenover FC, Tang YW, Nolte FS, Hayden RT, Belkum A (eds.). ASM Press, 2011; Chapter 28: pp453-462.

Publications:

  • Tu H, Avenarius MR, Kubatko L, Hunt M, Pan X, Ru P, Garee J, Thomas K, Mohler P, Pancholi P, Jones D. Distinct Patterns of Emergence of SARS‐CoV‐2 Spike Variants including N501Y in Clinical Samples in Columbus Ohio. bioRxiv 2021.01.12.426407; doi: https://doi.org/10.1101/2021.01.12.426407
  • Zhang S, Babady E, Hanson K, Harrington A, Larkin P, Leal S, Luethy P, Martin I , Pancholi P, Procop G, Riedel S, Seyedmousavi S, Sullivan K, Walsh T, Lockhart S. Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC) J. Clin Microbiol.2021 Jan 27;JCM.01784-20. doi: 10.1128/JCM.01784-20.
  • McLean K, Balada-Llasat JM, Waalkes A, *Pancholi P and *Salipante SJ.Whole-genome sequencing of clinical Clostridioides difficile isolates reveals molecular epidemiology and discrepancies with conventional laboratory diagnostic testing. Hosp Infect. 2021 Feb;108:64-71. doi: 10.1016/j.jhin.2020.11.014. Epub 2020 Nov 20.PMID: 33227298
  • Shah MD, Balada-Llasat JM, Coe K, Reed E, Pancholi, P. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results J Clin Microbiol. 2020 Apr 23;58(5):e01681-19. doi: 10.1128/JCM.01681-19. Print 2020 Apr 23. PMID: 32051264
  • Hebert C, Gao Y, Rahman P, Dewart C, Lustberg M, Pancholi P, Stevenson K, Shah NS, Hade EM. Prediction of Antibiotic Susceptibility for Urinary Tract Infection in a Hospital Setting. Antimicrob Agents Chemother. 2020 23;64(7):e02236-19. doi: 10.1128/AAC.02236-19.
  • Pancholi P, Young S, Widen R, Silbert S, Schmitt B, Dunn R, Drain A, Weissfeld SA. A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects. Diagn Microbiol Infect Dis. 2020 Jan; 96(1):114920. doi: 10.1016/j.diagmicrobio.2019.114920. Epub 2019 Oct 24. PMID:31699545
  • Lau AF, Walchak RC, Miller HB, Slechta S, Kamboj K, Riebe K, Robertson AE, Gilbreath JJ, Mitchell KM, Wallace MA, Bryson AL, Balada-Llasat JM, Bulman A, Buchan BW, Burnham CA, Butler-Wu S, Desai U, Doern CD, Hanson KE, Henderson CM, Kostrzewa M, Ledeboer NA, Maier T, Pancholi P, Schuetz AN, Shi G, Wengenack NL, Zhang SX, Zelazny AM, Frank KM. Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS. Frontiers in Laboratory Medicine. September 2019. https://doi.org/10.3389/fmicb.2019.02098
  • Daniels JB, Chen L, Grooters SV, Mollenkopf DF, Mathys DA, Pancholi P, Kreiswirth BN, Wittum TE. Enterobacter cloacae Complex Sequence Type 171 Isolates Expressing KPC-4 Carbapenemase Recovered from Canine Patients in Ohio. Antimicrob Agents Chemother 2018 26;62(12)
  • Vaughn JL, Balada-Llasat JM, Lamprecht M, Huang Y, Anghelina M, El Boghdadly Z, Bishop-Hill K, Childs R, Andritsos LA, Pancholi P. Detection of toxigenic Clostridium difficile colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation. J Med Microbiol. 2018 Jun 4. doi: 10.1099/jmm.0.000774.
  • Pancholi P, Carroll KC, Buchan BW, Chan RC, Dhiman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledeboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM. Multicenter Evaluation of the Accelerate PhenoTest™ BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.J Clin Microbiol. 2018 Jan 5. pii: JCM.01329-17. doi: 10.1128/JCM.01329-17.
  • Srinivas P, Hunt LN, Pouch SM, Thomas K, Goff DA, Pancholi P, Balada-Llasat JM, Bauer KA. Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates. Diagn Microbiol Infect Dis. 2018 Jun;91(2):194-198.
  • Chavez JA, Alexande AJ, Balada-Llasat JM, Pancholi P. A case of Wohlfahrtiimonas chitiniclastica bacteremia in continental United States. J. Med. Microbiology (2017, 4, doi: 10.1099/jmmcr.0.005134)
  • Zhang W, Bhowmik, A, Gopalakrishnan, Balada-Llasat JM, Pancholi, V, Pancholi, P. The role of LpxA/C/D and pmrA/B gene systems in colistin-resistant clinical strains of Acinetobacter baumannii. Frontiers in Laboratory Medicine. 2017.1: 86-91
  • Bauer KA, Johnston JEW, Wenzler E, Goff DA, Cook CH, Balada-Llasat JM, Pancholi P, Mangino JE. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection. Anaerobe. 2017. 48:1-6.
  • Haverkos BM, Huang Y, Gru A, Pancholi P, Freud AG, Mishra A, Ruppert AS, Baiocchi RA, Porcu P. Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas (PTCL). Int J Cancer. 2017 140(8):1899-1906